Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition

Infection and Immunity

Volumn 73, Issue 8, 2005, Pages 5249-5251

  Clark, Catherine J ^a   Mackay, Gillian M ^a   Smythe, George A ^b   Bustamante, Sonia ^b   Stone, Trevor W ^a   Phillips, R Stephen ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIMETHOXY N [4 (3 NITROPHENYL) 2 THIAZOLYL]BENZENESULFONAMIDE; 3,4 DIMETHOXY N [4 (3 NITROPHENYL)THIAZOL 2 YL]BENZENESULFONAMIDE; ANTHRANILIC ACID; KYNURENIC ACID; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PICOLINIC ACID; SULFONAMIDE; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MALARIA; MICROGLIA; MOUSE; NEUROLOGICAL COMPLICATION; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; ANTHRANILIC ACIDS; DISEASE MODELS, ANIMAL; KYNURENINE; KYNURENINE 3-MONOOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN-1; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MIXED FUNCTION OXYGENASES; PICOLINIC ACIDS; PLASMODIUM BERGHEI; SULFONAMIDES; THIAZOLES;

EID: 23344438452     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.8.5249-5251.2005     Document Type: Article

References (21)

1. Alberati-Giani, D., P. Ricciardi-Castagnoli, C. Kohler, and A. M. Cesura. 1996. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J. Neurochem. 66:996-1004.
2. Bosco, M. C., A. Rapisarda, S. Massazza, G. Melillo, H. Young, and L. Varesio. 2000. The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1α and -1β in macrophages. J. Immunol. 164:3283-3291.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Chen, L., and F. Sendo. 2001. Cytokine and chemokine mRNA expression in neutrophils from CBA/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria. Parasitol. Int. 50:139-143.
5. Chiarugi, A., and F. Moroni. 1999. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-di-methoxy-[N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase. Neuropharmacology 38:1225-1233.
6. Clark, C. J., R. S. Phillips, R. B. McMillan, I. O. Montgomery, and T. W. Stone. 2005. Differences in the neurochemical characteristics of the cortex and striatum of mice with cerebral malaria. Parasitology 130:23-29.
7. Dobbie, M., J. Crawley, C. Waruiru, K. Marsh, and R. Surtees. 2000. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? Am. J. Trop. Med. Hyg. 62:284-290.
8. Espey, M. G., O. N. Chernyshev, J. F. Reinhard, M. A. A. Namboodiri, and C. A. Colton. 1997. Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 8:431-434.
9. Glezer, I., C. D. Munhoz, E. M. Kawamoto, T. Marcourakis, M. C. Werneck Avellar, and C. Scavone. 2003. MK-801 and 7-Ni attenuate the activation of brain NF-κB induced by LPS. Neuropharmacology 45:1120-1129.
10. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24:491-499.
11. Jennings, V. M., J. K. Actor, A. A. Lal, and R. L. Hunter. 1997. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect. Immun. 65:4883-4887.
12. Jhamandas, K., R. J. Boegman, R. J. Beninger, and M. Bialik. 1990. Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites. Brain Res. 529:185-191.
13. Medana, I. M., N. P. J. Day, H. Salahifar-Sabet, R. Stocker, G. Smythe, L. Bwanaisa, A. Njobvu, K. Kayira, G. D. H. Turner, T. E. Taylor, and N. H. Hunt. 2003. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J. Infect. Dis. 188:844-849.
14. Medana, I. M., T. T. Hien, N. P. Day, N. H. Phu, N. T. H. Mai, L. Van Chu'ong, T. T. H. Chau, A. Taylor, H. Salahifar, R. Stocker, G. Smythe, G. D. H. Turner, J. Farrar, N. J. White, and N. H. Hunt. 2002. The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J. Infect. Dis. 185:650-656.
15. Neill, A. L., and N. H. Hunt. 1992. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105:165-175.
16. Röver, S., A. M. Cesura, P. Huguenin, R. Kettler, and A. Szente. 1997. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl) benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J. Med. Chem. 40:4378-4385.
17. Sanni, L. A., S. R. Thomas, B. N. Tattam, D. E. Moore, G. Chaudhri, R. Stocker, and N. H. Hunt. 1998. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am. J. Pathol. 152:611-619.
18. Smythe, G. A., O. Braga, B. J. Brew, R. S. Grant, G. J. Guillemin, S. J. Kerr, and D. W. Walker. 2002. Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry. Anal. Biochem. 301:21-26.
19. Stone, T. W. 2001. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64:185-218.
20. Stone, T. W., G. M. Mackay, C. M. Forrest, C. J. Clark, and L. G. Darlington. 2003. Tryptophan metabolites and brain disorders. Clin. Chem. Lab. Med. 41:852-859.
21. Wu, Y.-P., and R. L. Proia. 2004. Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice. Proc. Natl. Acad. Sci. USA 101:8425-8430.